In the METABRIC dataset, breast cancer patients (no particular subtyping) with high FGFR4 expression or amplified FGFR4 exhibited a significantly worse overall survival compared to breast cancer patients with unaltered FGFR4 (Fig. 5c). The gene discussed is FGFR4; the disease is breast cancer.